M&T Bank Corp Dbv Technologies S.A. Transaction History

M&T Bank Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$1.39 - $5.58 $37,481 - $150,464	-26,965 Closed	0 $0
Q1 2021 May 06, 2021	BUY	$2.75 - $6.57 $74,153 - $177,160	26,965 New	26,965 $144,000
Q3 2020 Nov 06, 2020	SELL	$1.58 - $4.77 $29,588 - $89,327	-18,727 Closed	0 $0
Q2 2020 Jul 29, 2020	BUY	$3.74 - $6.28 $4,738 - $7,956	1,267 Added 7.26%	18,727 $82,000
Q1 2020 May 14, 2020	BUY	$2.33 - $12.98 $4,687 - $26,115	2,012 Added 13.02%	17,460 $68,000
Q4 2019 Feb 07, 2020	BUY	$6.75 - $11.15 $17,968 - $29,681	2,662 Added 20.82%	15,448 $165,000
Q1 2019 May 15, 2019	BUY	$5.81 - $9.37 $74,286 - $119,804	12,786 New	12,786 $99,000

253K

Ticker DBVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,776,992
Market Cap $131M
Description
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

Stay updated on M&T Bank Corp with notifications on news.